1 – 139 of 139
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Non-Motor Symptom Management : Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients
(
- Contribution to journal › Article
-
Mark
Basal activity of PINK1 and PRKN in cell models and rodent brain
(
- Contribution to journal › Article
-
Mark
Association of Body Mass Index and Parkinson Disease A Bidirectional Mendelian Randomization Study
(
- Contribution to journal › Article
-
Mark
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
(
- Contribution to journal › Article
- 2023
-
Mark
Cell Replacement Therapy for Parkinson's Disease - Evaluating the potential of autologous grafting.
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Agreement between Parkinson Disease Home Diary and Observer Assessments before and after Structured Patient Training
(
- Contribution to journal › Article
-
Mark
Substitution of PINK1 Gly411 modulates substrate receptivity and turnover
(
- Contribution to journal › Article
-
Mark
Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson’s Disease Project
(
- Contribution to journal › Article
- 2022
-
Mark
Tau, bridging the gap between Alzheimer's and Parkinson's diseases
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells
(
- Contribution to journal › Article
-
Mark
Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease
(
- Contribution to journal › Article
-
Mark
Role of Neuroinflammation in Parkinson's Disease and Related Disorders
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease: Evidence from the COURAGE-PD Consortium
(
- Contribution to journal › Article
- 2021
-
Mark
Spectral Analysis of Body Movement during Deep Brain Stimulation in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Perceived walking difficulties in Parkinson’s disease – predictors and changes over time
(
- Contribution to journal › Article
-
Mark
Test-retest reliability of physical activity questionnaires in Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Social belonging as the main concern for achieving life satisfaction when adapting to parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture
(
- Contribution to journal › Article
-
Mark
Parkinson's Disease with Device, Diary, or in Disguise. Dyskinesia reduction, motor state evaluation, and workforce participation among persons with Parkinson's disease.
2021) In Lund University Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Validation and clinical value of the MANAGE-PD tool : A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
(
- Contribution to journal › Article
-
Mark
IFN-β rescues neurodegeneration by regulating mitochondrial fission via STAT5, PGAM5, and Drp1
(
- Contribution to journal › Article
- 2020
-
Mark
New generation genetic testing entering the clinic
(
- Contribution to journal › Article
-
Mark
Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism
(
- Contribution to journal › Article
- 2018
-
Mark
Experiences of fear of falling in persons with Parkinson's disease - A qualitative study
(
- Contribution to journal › Article
-
Mark
The Unbound Brain – A Thematic Introduction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Living with Lewy body dementia. Treatment, survival & quality of life.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The clinical significance of 10-m walk test standardizations in Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease : a multi-country Delphi-panel approach
(
- Contribution to journal › Article
- 2017
-
Mark
Challenges to informed consent in first-in-human trials involving novel treatments: A case study of Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Pericytes in Neurodegeneration
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Pathological creativity : How popular media connect neurological disease and creative practices
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Microglial cells in Neurodegenerative Diseases. The Role of Galectin-3
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Interpreting the brain in society : Cultural reflections on neuroscientific practices
- Book/Report › Anthology (editor)
-
Mark
Mixed emotions in the laboratory: When scientific knowledge confronts everyday knowledge
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Device-Aided Treatment Strategies in Advanced Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Walking difficulties is the main contributor to fear of falling in people with Parkinson’s disease
(
- Contribution to conference › Abstract
-
Mark
Psychometric properties of the original and short versions of the Falls Efficacy Scale-International (FES-I) in people with Parkinson's disease
(
- Contribution to journal › Article
- 2016
-
Mark
Health and social service access among family caregivers of people with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy
(
- Contribution to journal › Article
-
Mark
Statins are underused in recent-onset Parkinson's disease with increased vascular risk : findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
(
- Contribution to journal › Article
-
Mark
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
(
- Contribution to journal › Article
-
Mark
Development and external validation of a prognostic model in newly diagnosed Parkinson disease
(
- Contribution to journal › Article
-
Mark
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
(
- Contribution to journal › Article
-
Mark
Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Gray and white matter imaging : A biomarker for cognitive impairment in early Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.
2016) In Proceedings of the National Academy of Sciences of the United States of America 113(23). p.6544-6549(
- Contribution to journal › Article
-
Mark
Heterozygous PINK1 p.G411S mutation increases risk for Parkinson's disease (PD)
2016) 20th International Congress of Parkinson's Disease and Movement Disorders In Movement Disorders 31(Suppl. S2). p.282-282(
- Contribution to journal › Published meeting abstract
-
Mark
The restorative effect of PDGF-BB in Parkinson disease therapy
2016) FENS Forum 2016(
- Contribution to conference › Abstract
-
Mark
Life satisfaction in Parkinson's disease - associated factors
2016) The 20th International Congress of Parkinson's Disease and Movement Disorders(
- Contribution to conference › Abstract
- 2015
-
Mark
A novel combinational approach of microstimulation and bioluminescence imaging to study the mechanisms of action of cerebral electrical stimulation in mice
(
- Contribution to journal › Article
-
Mark
Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Anticholinergic Load : Is there a Cognitive Cost in Early Parkinson's Disease?
(
- Contribution to journal › Article
-
Mark
Tracking Parkinson's : Study Design and Baseline Patient Data
(
- Contribution to journal › Article
-
Mark
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Retrospective assessment of movement disorder society criteria for mild cognitive impairment in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals
(
- Contribution to journal › Article
-
Mark
Improving response inhibition in Parkinson's disease with atomoxetine
(
- Contribution to journal › Article
- 2014
-
Mark
Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling
(
- Contribution to journal › Article
-
Mark
Stem cell therapies for Parkinson's disease : are trials just around the corner?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Long-term clinical outcome of fetal cell transplantation for Parkinson disease : two case reports
(
- Contribution to journal › Article
-
Mark
Developing stem cell therapies for Parkinson's disease : waiting until the time is right
(
- Contribution to journal › Article
-
Mark
The Central Clock in Patients With Parkinson Disease — Reply
(
- Contribution to journal › Letter
-
Mark
Which patients with Parkinson's disease participate in clinical trials? : One centre's experiences with a new cell based therapy trial (TRANSEURO)
(
- Contribution to journal › Article
-
Mark
Mild cognitive impairment and Parkinson's disease - something to remember
(
- Contribution to journal › Article
-
Mark
Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Targeting impulsivity in Parkinson's disease using atomoxetine
(
- Contribution to journal › Article
-
Mark
Sleep and circadian rhythm regulation in early Parkinson disease
(
- Contribution to journal › Article
-
Mark
Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
(
- Contribution to journal › Article
-
Mark
Treating Parkinson's disease in the 21st century : can stem cell transplantation compete?
(
- Contribution to journal › Article
-
Mark
Quality of life and mild cognitive impairment in early Parkinson's disease : does subtype matter?
(
- Contribution to journal › Article
-
Mark
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease : a dose escalation, open-label, phase 1/2 trial
(
- Contribution to journal › Article
-
Mark
Characterizing mild cognitive impairment in incident Parkinson disease : the ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Predictors of Parkinson's disease dementia : towards targeted therapies for a heterogeneous disease
(
- Contribution to journal › Article
-
Mark
Health-related quality of life in early Parkinson's disease : the impact of nonmotor symptoms
(
- Contribution to journal › Article
-
Mark
The incidence of Parkinson's disease in the North-East of England
(
- Contribution to journal › Article
-
Mark
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
(
- Contribution to journal › Article
-
Mark
Neuroacanthocytosis - Clinical variability (a report on six cases)
2014) Eighteenth International Congress of Parkinson's Disease and Movement Disorders In Movement Disorders 29(Suppl 1). p.194-194(
- Contribution to journal › Published meeting abstract
-
Mark
Chapter 22 - Rodent Models of Treatment-Related Complications in Parkinson Disease
2014) p.373-386(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
(
- Contribution to journal › Article
-
Mark
LAMP2A as a therapeutic target in Parkinson disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The challenges of administering cell-based therapies to patients with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Linked clinical trials - the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments
(
- Contribution to journal › Article
-
Mark
Personality affects aspects of health-related quality of life in Parkinson's disease via psychological coping strategies
(
- Contribution to journal › Article
-
Mark
The relationship between abnormalities of saccadic and manual response times in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The CamPaIGN study of Parkinson's disease : 10-year outlook in an incident population-based cohort
(
- Contribution to journal › Article
- 2012
-
Mark
Accuracy and Sensitivity of Parkinsonian Disorder Diagnoses in Two Swedish National Health Registers
(
- Contribution to journal › Article
-
Mark
Inflammation and neurodegeneration : the story 'retolled'
(
- Contribution to journal › Article
-
Mark
Pharmacological modulation of amphetamine-induced dyskinesia in transplanted hemi-parkinsonian rats
(
- Contribution to journal › Article
-
Mark
Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy
(
- Contribution to journal › Article
-
Mark
Large-scale replication and heterogeneity in Parkinson disease genetic loci
(
- Contribution to journal › Article
- 2011
-
Mark
Measurement Properties of the SF-12 Health Survey in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease
(
- Contribution to journal › Article
- 2010
-
Mark
Recent advances in Parkinson's disease : basic research. Preface
(
- Contribution to journal › Article
-
Mark
Preface
(
- Chapter in Book/Report/Conference proceeding › Foreword/Postscript
-
Mark
Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease : large-scale collaborative study
(
- Contribution to journal › Article
- 2009
-
Mark
Rodent models of treatment-induced motor complications in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
A decision tool to support appropriate referral for deep brain stimulation in Parkinson's disease
(
- Contribution to journal › Article
- 2008
-
Mark
Complete ascertainment of Parkinson disease in the Swedish Twin Registry
(
- Contribution to journal › Article
-
Mark
Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias
(
- Contribution to journal › Article
- 2007
-
Mark
Tracking the neurodegeneration of parkinsonian disorders - A pilot study
(
- Contribution to journal › Article
-
Mark
The functional impact of the intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease
(
- Contribution to journal › Article
- 2005
-
Mark
Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
(
- Contribution to journal › Article
- 2004
-
Mark
Life span extension and reduced neuronal death after weekly intraventricular cyclosporin injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis
(
- Contribution to journal › Article
-
Mark
Cell replacement therapy : helping the brain to repair itself
(
- Contribution to journal › Debate/Note/Editorial
- 2002
-
Mark
Role of cell therapy in Parkinson disease.
(
- Contribution to journal › Article
- 2000
-
Mark
The influence of pallidal deep brain stimulation on striatal dopaminergic metabolism in the rat
(
- Contribution to journal › Article
-
Mark
Neural tissue xenografting
(
- Contribution to journal › Article
-
Mark
Attitudes to xenotransplantation : interviews with patients suffering from Parkinson's disease focusing on the conception of risk
(
- Contribution to journal › Article
-
Mark
Neural tissue xenografting in neurodegenerative disorders : countdown to a clinical trial
(
- Contribution to journal › Published meeting abstract
-
Mark
Patientröster om xenotransplantation: "jag skulle göra allt, för jag vill inte dö!"
(
- Contribution to journal › Article
-
Mark
Neural tissue xenotransplantation : What Is Needed Prior to Clinical Trials in Parkinson’s Disease?
(
- Contribution to journal › Article
- 1999
-
Mark
Porcine embryonic brain cell cytotoxicity mediated by human natural killer cells
(
- Contribution to journal › Article
-
Mark
Dyskinesias assessment : From CAPIT to CAPSIT. Core Assessment Program for Intracerebral Transplantations. Core Assessment Program for Surgical Interventional Therapies
(
- Contribution to journal › Article
-
Mark
Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD)
(
- Contribution to journal › Article
-
Mark
The case for neural tissue transplantation as a treatment for Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Review of allo- and xenogeneic neural grafts in neurodegenerative disorders. Neural Tissue Transplantation Team(NETTLU)
(
- Contribution to journal › Scientific review
- 1998
-
Mark
Trophic effect of porcine Sertoli cells on rat and human ventral mesencephalic cells and hNT neurons in vitro
(
- Contribution to journal › Article
- 1995
-
Mark
Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease
(
- Contribution to journal › Article
- 1994
-
Mark
Lazaroids improve the survival of grafted rat embryonic dopamine neurons
1994) In Proceedings of the National Academy of Sciences of the United States of America 91(26). p.12-12408(
- Contribution to journal › Article
-
Mark
NIH neural transplantation funding
(
- Contribution to journal › Letter
-
Mark
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease
(
- Contribution to journal › Article
- 1993
-
Mark
Transplantation and surgical treatment of parkinsonian syndromes
(
- Contribution to journal › Article
-
Mark
Immature neural tissue grafts in Parkinson's disease
(
- Contribution to journal › Article
- 1992
-
Mark
Transplantation of fetal dopamine neurons in Parkinson's disease : PET [18F]6-L-fluorodopa studies in two patients with putaminal implants
(
- Contribution to journal › Article
-
Mark
Transplantation of fetal dopamine neurons in Parkinson's disease : one-year clinical and neurophysiological observations in two patients with putaminal implants
(
- Contribution to journal › Article
-
Mark
Core assessment program for intracerebral transplantations (CAPIT)
(
- Contribution to journal › Article
- 1991
-
Mark
Transplanted allogeneic fetal dopamine neurons survive and improve motor function in idiopathic Parkinson's disease
(
- Contribution to journal › Article
- 1990
-
Mark
Chapter 83 Neural transplantation in Parkinson's disease : the Swedish experience
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Nya lovande resultat med transplantation av nervceller till hjärnan vid Parkinsons sjukdom
(
- Contribution to journal › Article
-
Mark
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
(
- Contribution to journal › Article
- 1989
-
Mark
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up
(
- Contribution to journal › Article
- 1988
-
Mark
Fetal dopamine-rich mesencephalic grafts in Parkinson's disease
(
- Contribution to journal › Letter
-
Mark
Human fetal dopamine neurons grafted in a rat model of Parkinson's disease : immunological aspects, spontaneous and drug-induced behaviour, and dopamine release
(
- Contribution to journal › Article
-
Mark
Can human fetal dopamine neuron grafts provide a therapy for Parkinson's disease?
(
- Contribution to journal › Scientific review
- 1987
-
Mark
Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease
(
- Contribution to journal › Article